Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Junfeng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neovascularization, Pathologic, Transforming Growth Factor beta, Cell Proliferation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a common digestive tract tumor with the third incidence and death in the world. There is still an urgent need for effective therapeutic targets and prognostic markers for CRC. Herein, we report a novel potential target and marker, Chordin like‐1 (CHRDL1). The function of CHRDL1 has been reported in gastric cancer, breast cancer, and oral squamous cell carcinoma. However, the biological effect of CHRDL1 in CRC remains unrevealed. Transwell and tube formation experiments were used to determine the biological function of CHRDL1. Western blot and rescue experiments were used to determine the specific mechanisms of CHRDL1. Results showed CHRDL1 is significantly downregulated in CRC cell lines and tissues. In vitro, experiments confirmed that CHRDL1 can inhibit cell growth, migration, invasion, angiogenesis and reverse epithelial‐mesenchymal transformation. In vivo, experiments proved that it can inhibit tumor growth and metastasis. Mechanistically, we newly find that CHRDL1 exerts biological functions through the transforming growth factor‐beta (TGF‐β)/vascular endothelial growth factor signaling axis in vitro and in vivo. Therefore, we concluded that CHRDL1 reduces the growth, migration, and angiogenesis of CRC cells by downregulating TGF‐β signaling. Our new findings on CHRDL1 may provide a basis for clinical antiangiogenesis therapy and the prognosis of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Jun Chen, Zheng Jiang
Zitieren
APA
Li, J., Jiang, Z., He, J., Yang, K., Chen, J., Deng, Q., Li, X., Wu, F., Xu, S., & Jiang, Z. (2024). Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23711
Vancouver
Li J, Jiang Z, He J, Yang K, Chen J, Deng Q, et al. Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23711
BibTeX
@article{Li2024,
author = {Li, Junfeng and Jiang, Zhongxiang and He, Jin and Yang, Kun and Chen, Jun and Deng, Qianxi and Li, Xiaoqing and Wu, Fan and Xu, Shuman and Jiang, Zheng},
title = {Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23711}
}
EUVIMED